IP Library › Granted Patent US 12,208,387
Granted Patent B2
US 12,208,387 · App. 18/262,375 · Granted Jan 28, 2025

Apparatus and methods for selective capture of mycobacteria

Inventors: Digvijay Singh (Baltimore, MD); Bonolo Mathekga (Baltimore, MD); Yukari Manabe (Elkridge, MD); Soumyadipta Acharya (Ellicott City, MD); Hai Quan Mao (Baltimore, MD)
Assignee: Drizzle Health LLC
B01L3/502707C12N1/205C12N11/08B01L2200/10C12R2001/32
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,208,387
App. No.
18/262,375
Granted
Jan 28, 2025
Kind
B2
Abstract

A device for selectively capturing mycobacteria comprises a substrate and a capture polymer layer of poly-diallyldimethyl ammonium chloride, wherein the capture polymer layer is covalently linked onto the substrate via a UV-initiated polymerization reaction of a solution comprising diallyldimethyl ammonium chloride and a photoinitiator in water purged of dissolved oxygen, and wherein the UV exposure time is 30 seconds to 4 minutes at a power density of about 20 to about 25 mW/cm 2 . A kit can comprise the device. A microfluidic chip comprises at least a portion of at least one channel sidewall coated with a capture polymer layer of poly-diallyldimethyl ammonium chloride. A method for manufacturing the device includes plasma treating a substrate, providing a solution comprising diallyldimethyl ammonium chloride and a photoinitiator in water purged of dissolved oxygen, and coating the plasma-treated substrate via a UV-initiated polymerization reaction.

Claims (32)

1. A method of manufacturing a device for selective capture of mycobacteria, the method comprising:

providing a substrate;

plasma treating the substrate to generate a plasma-treated substrate;

providing an aqueous monomer solution comprising diallyldimethyl ammonium chloride and a photoinitiator in water purged of dissolved oxygen;

covalently linking a capture polymer layer of poly-diallyldimethyl ammonium chloride to the plasma-treated substrate by applying the aqueous monomer solution to the plasma-treated substrate via a UV-initiated polymerization reaction,

wherein a UV exposure time is about 30 seconds to about 4 minutes at a power density of about 20 mW/cm 2 to about 25 mW/cm 2 ; and

cooling the plasma-treated substrate to about 0 degrees Celsius to about 20 degrees Celsius.

2. The method of claim 1 , wherein the plasma treating the substrate is with an oxygen plasma treatment.

3. The method of claim 1 , wherein the plasma treating the substrate is for about 5 to about 15 minutes at an RF power setting of about 20 W to about 35 W.

4. The method of claim 1 , wherein cooling the plasma-treated substrate is for about 30 seconds to about 30 minutes.

5. The method of claim 1 , wherein the aqueous monomer solution is about 7% to about 12% diallyldimethyl ammonium chloride by weight.

6. The method of claim 1 , wherein the photoinitiator is 2-Hydroxy-4′-(2-hydroxyethoxy)-2-methylpropiophenone.

7. The method of claim 1 , wherein the aqueous monomer solution additionally comprises an alcohol selected from the group consisting of: methanol, ethanol, propanol, and butanol.

8. The method of claim 1 , wherein the UV exposure time is about 50 seconds to about 1 minute and 10 seconds.

9. The method of claim 1 , wherein the substrate comprises polystyrene.

10. The method of claim 1 , wherein the substrate is a solid substrate.

11. The method of claim 1 , wherein the aqueous monomer solution is about 8.9% diallyldimethyl ammonium chloride by weight.

12. The method of claim 1 , wherein the aqueous monomer solution is about 8% to about 10% diallyldimethyl ammonium chloride by weight.

13. A method of manufacturing a device for selective capture of mycobacteria, the method comprising:

providing a substrate;

plasma treating the substrate to generate a plasma-treated substrate;

providing an aqueous monomer solution comprising diallyldimethyl ammonium chloride and a photoinitiator;

covalently linking a capture polymer layer of poly-diallyldimethyl ammonium chloride to the plasma-treated substrate by applying the aqueous monomer solution to the plasma-treated substrate via a UV-initiated polymerization reaction; and

cooling the plasma-treated substrate to about 0 degrees Celsius to about 20 degrees Celsius for about 30 seconds to about 30 minutes.

14. The method of claim 13 , wherein the plasma treating the substrate is with an oxygen plasma treatment.

15. The method of claim 13 , wherein the plasma treating the substrate is for about 5 minutes to about 15 minutes.

16. The method of claim 15 , wherein the plasma treating the substrate is at an RF power setting of about 20 W to about 35 W.

17. The method of claim 13 , wherein the aqueous monomer solution is about 7% to about 12% diallyldimethyl ammonium chloride by weight.

18. The method of claim 13 , wherein the photoinitiator is 2-Hydroxy-4′-(2-hydroxyethoxy)-2-methylpropiophenone.

19. The method of claim 13 , wherein the aqueous monomer solution additionally comprises an alcohol selected from the group consisting of: methanol, ethanol, propanol, and butanol.

20. The method of claim 13 , wherein a UV exposure time, for the UV-initiated polymerization reaction, is about 50 seconds to about 1 minute and 10 seconds.

21. The method of claim 13 , wherein the substrate comprises polystyrene.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 20, 2023
From: SINGH, DIGVIJAY; MATHEKGA, BONOLO; MANABE, YUKARI; ACHARYA, SOUMYADIPTA; MAO, HAI QUAN
To: DRIZZLE HEALTH LLC
Reel/Frame 064333/0070 →
Continuity (2)
Provisional Application 63140465 · Jan 22, 2021
Related Publication 20240042430A1 · Feb 8, 2024
References Cited (14)
US 8574923B2 · Cooney et al. · 2013 [cited by applicant]
US 8603771B2 · Stanley et al. · 2013 [cited by applicant]
US 10577654B2 · Grass et al. · 2020 [cited by applicant]
US 20030165428A1 · McCombs · 2003 [cited by applicant]
US 20100203521A1 · Klapperich et al. · 2010 [cited by applicant]
US 20150203645A1 · Rasmussen · 2015 [cited by examiner]
US 20150321191A1 · Kendall · 2015 [cited by examiner]
US 20170067088A1 · O'Brien-Coon · 2017 [cited by examiner]
Grimaldi et al., Plasma functionalization procedure for antibody immobilization for SU-8 based sensor, 2016, Biosensors and Bioelectronics, 86, p. 827-833. (Year: 2016). [cited by examiner]
Lee et al., Inactivation of Mycobacteria by Radicals from Non-Thermal Plasma Jet, 2019, J. Microbiol. Biotechnol., 29(9), p. 1401-1411. (Year: 2019). [cited by examiner]
Beaulieu et al., Oxygen Plasma Treatment of Polystyrene and Zeonor: Substrates for Adhesion of Patterned Cells, 2009, American Chemical Society, vol. 25, p. 7169-7176. (Year: 2009). [cited by examiner]
Jiang et al., Selective mycobacterial capture with ultraviolet-polymerized polydimethyldiallyl chloride functionalized surfaces, 2024, Journal of Materials Science: Materials in Medicine, 35:57, p. 1-10. (Year: 2024). [cited by examiner]
International Search Report re PCT/US2022/013433 dated Apr. 11, 2022 (2 pages). [cited by applicant]
Written Opinion re PCT/US2022/013433 dated Apr. 11, 2022 (7 pages). [cited by applicant]